Lutz Lingnau, Director at NEKTAR THERAPEUTICS (NKTR), sold 12,500 shares at $12.00 ($150K) on 2015-10-28, disclosed to the SEC on 2015-10-30.
Scheduled sale ($150k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NKTR | SELL | 2018-09-21 | $513K | — | Filing → |
| NKTR | SELL | 2018-04-09 | $3.1M | — | Filing → |
| NKTR | SELL | 2017-09-25 | $110K | — | Filing → |